COGT
Price
$5.98
Change
+$0.34 (+6.03%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
680.86M
68 days until earnings call
CRNX
Price
$32.32
Change
+$0.19 (+0.59%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
3.03B
64 days until earnings call
Interact to see
Advertisement

COGT vs CRNX

Header iconCOGT vs CRNX Comparison
Open Charts COGT vs CRNXBanner chart's image
Cogent Biosciences
Price$5.98
Change+$0.34 (+6.03%)
Volume$34.82K
Capitalization680.86M
Crinetics Pharmaceuticals
Price$32.32
Change+$0.19 (+0.59%)
Volume$7.99K
Capitalization3.03B
COGT vs CRNX Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. CRNX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and CRNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (COGT: $5.64 vs. CRNX: $32.13)
Brand notoriety: COGT and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 59% vs. CRNX: 54%
Market capitalization -- COGT: $642.15M vs. CRNX: $3.01B
COGT [@Biotechnology] is valued at $642.15M. CRNX’s [@Biotechnology] market capitalization is $3.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 3 bearish.
  • CRNX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COGT is a better buy in the short-term than CRNX.

Price Growth

COGT (@Biotechnology) experienced а +15.57% price change this week, while CRNX (@Biotechnology) price change was +7.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.03B) has a higher market cap than COGT($681M). COGT YTD gains are higher at: -27.692 vs. CRNX (-37.160). COGT has higher annual earnings (EBITDA): -284.04M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. COGT (246M). COGT has less debt than CRNX: COGT (17.1M) vs CRNX (50.8M). CRNX has higher revenues than COGT: CRNX (760K) vs COGT (0).
COGTCRNXCOGT / CRNX
Capitalization681M3.03B22%
EBITDA-284.04M-373.49M76%
Gain YTD-27.692-37.16075%
P/E RatioN/AN/A-
Revenue0760K-
Total Cash246M1.27B19%
Total Debt17.1M50.8M34%
FUNDAMENTALS RATINGS
COGT vs CRNX: Fundamental Ratings
COGT
CRNX
OUTLOOK RATING
1..100
138
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
7366
SMR RATING
1..100
9651
PRICE GROWTH RATING
1..100
8483
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (81) in the Miscellaneous industry is in the same range as CRNX (92) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is in the same range as COGT (73) in the Miscellaneous industry. This means that CRNX’s stock grew similarly to COGT’s over the last 12 months.

CRNX's SMR Rating (51) in the Pharmaceuticals Major industry is somewhat better than the same rating for COGT (96) in the Miscellaneous industry. This means that CRNX’s stock grew somewhat faster than COGT’s over the last 12 months.

CRNX's Price Growth Rating (83) in the Pharmaceuticals Major industry is in the same range as COGT (84) in the Miscellaneous industry. This means that CRNX’s stock grew similarly to COGT’s over the last 12 months.

CRNX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as COGT (100) in the Miscellaneous industry. This means that CRNX’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTCRNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APFDX22.050.23
+1.05%
Artisan Global Discovery Investor
FTANX12.10N/A
N/A
Fidelity Asset Manager 30%
LLINX16.66N/A
N/A
Longleaf Partners International
FEIKX77.53N/A
N/A
Fidelity Equity-Income K
UDPSX62.74N/A
N/A
ProFunds Ultra Dow 30 Svc

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-2.59%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
54%
Loosely correlated
-0.44%
IDYA - COGT
53%
Loosely correlated
-2.50%
RARE - COGT
52%
Loosely correlated
+0.58%
CRNX - COGT
52%
Loosely correlated
+0.78%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.78%
XNCR - CRNX
58%
Loosely correlated
-0.44%
IDYA - CRNX
56%
Loosely correlated
-2.50%
DYN - CRNX
56%
Loosely correlated
+1.06%
TRDA - CRNX
55%
Loosely correlated
-3.76%
RVMD - CRNX
55%
Loosely correlated
-0.49%
More